Zai Lab Ltd·4

Jan 3, 7:25 PM ET

Reinhart Harald 4

4 · Zai Lab Ltd · Filed Jan 3, 2024

Insider Transaction Report

Form 4
Period: 2024-01-01
Reinhart Harald
Chief Medical Officer
Transactions
  • Exercise/Conversion

    American Depositary Shares

    2024-01-01+17,54850,863 total
  • Award

    Performance-Based Share Units

    2024-01-01+17,54817,548 total
    American Depositary Shares (17,548 underlying)
  • Sale

    American Depositary Shares

    2024-01-03$26.12/sh4,803$125,46446,060 total
  • Exercise/Conversion

    Performance-Based Share Units

    2024-01-0117,5480 total
    American Depositary Shares (17,548 underlying)
Footnotes (5)
  • [F1]Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
  • [F2]ADSs acquired on vesting of performance-based share units (PSUs). Each ADS represents ten Ordinary Shares of the issuer.
  • [F3]Each PSU represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
  • [F4]These ADSs were sold automatically to cover taxes upon vesting of PSUs.
  • [F5]The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs.

Documents

1 file
  • 4
    form4.xmlPrimary